Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
about
Music therapy can lower the heart rates of severely sick children.Identification of a candidate proteomic signature to discriminate multipotent and non-multipotent stromal cells.Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donorsLong-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years.Kidney diseases associated with haematological cancers.Patients' experiences of different care settings and a new life situation after allogeneic haematopoietic stem cell transplantation.Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation.Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT.Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients.Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest?Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation.Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital.General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.Similar survival, but better quality of life after myeloablative transplantation using unrelated cord blood vs matched sibling donors in adults with hematologic malignancies.Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD).Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.Occupational status among adult survivors following allogeneic stem cell transplantation in childhood.Histologic analysis has a prognostical value in colorectal biopsies assessed for suspicion of graft-versus-host disease.Rates and predictors of psychotherapy utilization after psychosocial evaluation for stem cell transplant.Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients.Danaparoid reduces transplant-related mortality in stem cell transplantation for children.Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie CWhat is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.Cataract after allogeneic hematopoietic stem cell transplantation in childhood.Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index.Four decades of stem cell transplantation for Fanconi anaemia in the Netherlands.Bone marrow aspiration technique has deteriorated in recent years.Active acute leukaemia: should transplant be offered to all patients?
P2860
Q30387478-8337CCB2-A6E4-4A35-A6BD-0F53B445770FQ31068753-BB08FE73-F4B2-4294-888A-08B9D53A8C78Q34413233-ACAEAC5E-6C7A-497D-99D9-7538FAEA7305Q36010605-081A8E9C-B40A-4056-AB27-6094E3E5EF09Q38124392-ED803FAF-9088-448A-BE3A-B8AAF2989715Q38513113-C4D430E3-9F19-4F58-A71B-443D4D98C76CQ38751585-EBCC3A6E-0267-4352-8A13-40C516C053A7Q39202357-86DF7608-A9CD-4323-9C87-8135D33E74A8Q40122841-72B83181-9695-4B29-AE24-EF0062C06CB0Q40288619-836271EF-9422-4C06-AB4B-9682A7F445CEQ40373921-8F50C226-656E-4353-9AB8-409EEF67D2E3Q41046376-320C7FC2-062C-44EB-AB84-78F55285B601Q41520774-4E5E1CE4-DC2D-4118-9D30-37880A96F6C2Q41742166-31A972D7-5221-4E5A-940D-E6BAC4A5F69AQ43486658-CC6D3EDD-AB79-42E3-8350-9D8E079DD0A2Q43988469-261089F7-4F90-460E-A2B9-F0D23455E429Q44059940-2CB39D77-6246-4333-8E61-1EF50477E126Q45243246-9D7BDCC1-3AF3-4EC2-A9F1-442396A81008Q45866879-4A24203A-B3D1-4D00-BAF2-B5526BDFFBD2Q47189367-CFB7BF6B-0A68-4022-90D0-4203CD08D5DFQ47425400-22BC3A69-23DC-4163-89E3-A355EA9DBEFCQ47860871-A92EF438-875E-4BA9-95EE-A873FEA97235Q47955823-406E5DC6-1056-4A8E-91C4-627BA9E047E3Q48119892-CA52D031-2DD0-4662-BB9E-0D2DEE3E40F7Q48144263-0AD23D2C-E37D-4A69-A54F-01470EE5DE5AQ48191465-BDD1D227-91C2-453B-9C87-A7872225ED6BQ48295098-451F03DC-77C4-46FA-85DE-6909F2360671Q50989345-FD113171-320D-49F5-8DEB-529FAF64B157Q52881816-94A981AD-46A7-4D1D-8674-BE115571CE30Q52984834-59E6E2B0-BB1F-4CD0-AF55-918A4E6C4027Q53536804-D2600488-E331-494D-8256-AA2AD70488FFQ54052781-55551DED-7D7D-4856-BC8D-BDB3B111262C
P2860
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
description
im Mai 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 11 May 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2011
@uk
name
Improved Survival after Alloge ...... t Years. A Single-Center Study
@en
Improved Survival after Alloge ...... t Years. A Single-Center Study
@nl
type
label
Improved Survival after Alloge ...... t Years. A Single-Center Study
@en
Improved Survival after Alloge ...... t Years. A Single-Center Study
@nl
prefLabel
Improved Survival after Alloge ...... t Years. A Single-Center Study
@en
Improved Survival after Alloge ...... t Years. A Single-Center Study
@nl
P2093
P50
P1476
Improved survival after alloge ...... t years. A single-center study
@en
P2093
Agneta Wikman
Ann-Charlotte Wikström
Attila Szakos
Brigitta Omazic
Britt Gustafsson
Britt-Marie Svahn
Dan Hauzenberger
Darius Sairafi
Gunilla Kumlien
P304
P356
10.1016/J.BBMT.2011.05.001
P50
P577
2011-05-11T00:00:00Z